Movement Disorders

Movement Disorders

Alpha-synuclein aggregation in the olfactory mucosa of patients with isolated RBD vs. PD 2:54
Alpha-synuclein aggregation in the olfactory mucosa of patients with isolated RBD vs. PD
Ambra Stefani • 23 Jun 2021
LECIG for motor fluctuations in Parkinson’s disease 3:28
LECIG for motor fluctuations in Parkinson’s disease
Dag Nyholm • 24 Jun 2021
REM sleep behavior disorder: a marker of risk/progression in PD? 3:30
REM sleep behavior disorder: a marker of risk/progression in PD?
Claudia Trenkwalder • 9 Jun 2021
The latest research on REM sleep behavior disorder 3:07
The latest research on REM sleep behavior disorder
Claudia Trenkwalder • 9 Jun 2021
Brain-first and body-first Parkinson’s disease: are there subgroups of prodromal patients? 9:12
Brain-first and body-first Parkinson’s disease: are there subgroups of prodromal patients?
Filip Scheperjans • 1 Jun 2021
Genetic testing is becoming increasingly important in Parkinson’s disease 2:00
Genetic testing is becoming increasingly important in Parkinson’s disease
Alessio Di Fonzo • 14 Jun 2021
The impact of genetics on Parkinson’s disease management 3:38
The impact of genetics on Parkinson’s disease management
Alessio Di Fonzo • 14 Jun 2021
Treating Parkinson’s disease with gene editing 1:43
Treating Parkinson’s disease with gene editing
Alessio Di Fonzo • 14 Jun 2021
Origins and progression of Parkinson’s disease 3:27
Origins and progression of Parkinson’s disease
Tiago Outeiro • 18 Jun 2021
Sleep, mood & pain in PD patients treated with safinamide 2:41
Sleep, mood & pain in PD patients treated with safinamide
Diego Santos-García • 7 Jun 2021
Movement disorders: interventions to reduce acute hospital admission due to falls 1:48
Movement disorders: interventions to reduce acute hospital admission due to falls
Diego Santos-García • 7 Jun 2021
Microbiota-targeting agents for Parkinson’s disease 1:52
Microbiota-targeting agents for Parkinson’s disease
Filip Scheperjans • 1 Jun 2021
Falls predict acute hospitalization in Parkinson’s disease 3:38
Falls predict acute hospitalization in Parkinson’s disease
Diego Santos-García • 7 Jun 2021
SAFINONMOTOR: safinamide for Parkinson’s disease non-motor symptoms 3:22
SAFINONMOTOR: safinamide for Parkinson’s disease non-motor symptoms
Diego Santos-García • 7 Jun 2021
Can we achieve a clinically actionable test of the gut microbiome for neurodegenerative disorders? 3:21
Can we achieve a clinically actionable test of the gut microbiome for neurodegenerative disorders?
Filip Scheperjans • 1 Jun 2021
Investigating the gut microbiome in Parkinson’s disease 2:59
Investigating the gut microbiome in Parkinson’s disease
Filip Scheperjans • 1 Jun 2021
The content of VJNeurology is intended for healthcare professionals